U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06874114) titled 'An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men with Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care' on Feb. 21.

Brief Summary: This is an observational study in which only data are collected from adult Canadian men with metastatic hormone sensitive prostate cancer (mHSPC) are studied. Participants will not receive any advice on treatment or any changes to the healthcare.

Metastatic hormone sensitive prostate cancer is a cancer of the prostate gland, a male reproductive gland found below the bladder. Metastatic means that cancer has...